Thank you, David. Turning to slide 11. And a review of our Q4 results from continuing operations. Beginning with our net sales. Net sales decreased 5.2% excluding the impact of $10.5 million of favorable foreign exchange. Organic net sales decreased 6.6% primarily driven by supply constraints as a result of our decision to pause purchases from China for the US market during the third quarter and continued category softness in our global pet care and home and personal care business. These headwinds were partially offset by a delayed start to the season for our home and garden business that benefited current quarter results. Gross profit decreased $31.4 million and gross margins of 35% decreased 220 basis points largely driven by lower volume, unfavorable mix, inflation, and higher tariffs. Partially offset by pricing, cost improvement actions, and favorable effects. Operating expenses of just over $227 million decreased 14.6%, due to lower spend in advertising and marketing, and general expense management in light of category softness. As well as lower restructuring-related project spend. Operating income of $29.4 million increased by $7.5 million due to the lower operating expenses, partially offset by a decline in gross profit. GAAP net income and diluted earnings per share both increased, primarily driven by a one-time tax benefit for the quarter resulting from a tax entity realignment initiative. Lower share count, and higher operating income. Adjusted EBITDA was $63.4 million, a decrease of $5.5 million driven by lower volume and reduced gross margins partially offset by lower operating expenses. Adjusted diluted EPS increased to $2.61 driven by a one-time tax benefit that I referenced earlier. And the reduction in shares outstanding partially offset by lower adjusted EBITDA. Turning to slide 12. Q4 interest expense from continuing operations of $7.9 million increased $1.2 million due to higher average borrowing on our cash flow revolver in the current quarter. Cash taxes during the quarter decreased $10.2 million from the prior year. Depreciation and amortization of $23.9 million decreased $1.7 million from last year. And separately, share-based compensation increased to $5.8 million from $4.6 million in the prior year. Capital expenditures were $13.2 million in Q4, essentially flat to last year. Cash payment towards strategic transactions restructuring-related projects, and other unusual nonrecurring adjustments were $7.3 million versus $10 million last year. Moving to the balance sheet. We had a quarter-end cash balance of $123.6 million and $492.3 million available on our $500 million cash flow revolver. Total debt outstanding was approximately $581.4 million consisting of $496 million senior unsecured notes and $85.3 million of finance leases. We ended the quarter with $457.8 million of net debt. Turning to Slide 13 and an overview of our full-year results. Net sales decreased 5.2% and organic net sales decreased 5.3%. Sales performance was driven by category softness in light of macroeconomic conditions and supply shortages, from the six to eight weeks pause previously mentioned. These had been significantly impacted results both in our global pet care and home and personal care businesses. Despite strong performance by our key brands, sales in the home and garden business were modestly down driven by unfavorable weather conditions. Full-year gross profit decreased by $77.4 million and gross margin of 36.7% decreased 70 basis points driven by lower volume, higher inflation, increased tariff costs, and unfavorable mix. This was partially offset by cost improvement initiative pricing, and favorable FX. Adjusted EBITDA decreased to $289.1 million excluding investment income of $52.7 million in the prior year, Adjusted EBITDA decreased $30 million or 9.4% primarily driven by lower volume, and a decline in gross profit, partially offset by a reduction in operating expenses. Adjusted free cash flow was $170.7 million, or approximately $7 per share. $7 cash per share. Exceeding the $160 million free cash flow framework previously provided. During the year, we prioritized the health of our balance sheet through active management of CapEx investments, and improved working capital. Now let's get into a review of each business unit where I'll provide you more details on the underlying performance drivers of our operational results. I'll start with our global pet care business. Which is slide 14. Reported net sales decreased 1.5% and excluding favorable foreign currency impact, organic net sales decreased 3.3%. Sales in Aquatics increased high single digits offset by mid-single digits decline in companion animals. North America, companion animal brands continue to trend favorably. Our brands maintained or gained market share driven by innovation and successful commercial activations. With our retail partners in spite of category softness. In aquatics, we successfully mitigated category declines and delivered improved results. Driven by distribution gains in pet specialty and mass channel. Comparisons for the quarter in both companion animal and aquatics were impacted by a strategic pull forward of orders by retailers in the prior year in preparation for our S/4HANA ERP implementation. Resulting in an approximately $10 million headwind for the quarter. Also as expected, our decisions to pause shipments for a six to eight weeks period when tariffs were at their highest point during the third quarter led to continued supply shortages during the current quarter. Our inventory levels are now generally healthy, and shortages are not expected to be a significant headwind heading into fiscal 2026. Conversely, results were favorably impacted by our decisions in the third quarter to stop shipment to a key retailer as tariff pricing negotiations stalled. By the end of the third quarter, negotiations were complete but it did result in shipment delays benefiting our fourth quarter results. In EMEA, companion animal sales increased driven by the continued strength of our Good Boy brand, market share gains, in the UK, and expanding further in Continental Europe. Net sales also increased in our dog and cat food led by our Eucanuba brand. Aquatic sales also increased with the TETRA brand gaining shares in key markets mitigating category softness. Our innovation continues to resonate with the consumer. And is largely focused on further expansion into adjacent categories. Green Bone Collium, you may recall we recently launched a product that focuses on health and wellness benefits for pets. We also continue to launch new innovations in the treats categories, as our Good and Tasty product launches continue to perform well with further plans of expansion and more unique innovations, coming in the coming months. Our investments in Nature's Miracle also continue to yield results as the brand is gaining share and new points of distributions. In the fourth quarter, Nature's Miracle grew across pure play online, mass, food, dollar, and drug channels. Our Good Boy brand is the number one brand in dog shoes in the UK, and it's the fourth largest brand in overall pet and continues to grow market share driven by consistent innovation. The brand's expansion across Continental Europe continues to perform really well. Most recently becoming one of the top five treat brands in The Netherlands. In dog and cat food, we are continuing to expand IMs into more markets. And recently launched a refreshed portfolio on Yukonuba. This quarter's adjusted EBITDA of $49.6 million is $5.3 million higher than the previous year. An adjusted EBITDA margin was 16.6% compared to 14.6% last year. The improvement to adjusted EBITDA was primarily driven by expense management through cost savings initiatives announced earlier in the year lower investment spend due to category softness, and pricing. These actions more than offset the lower sales volume, higher tariff cost, and inflation experienced in the quarter. While GPC's fiscal 2025 sales fell short of the prior year due to macroeconomic and category headwinds, we believe the business is well-positioned heading into fiscal 2026. And we expect to return to modest growth as underlying category fundamentals and macroeconomic trends begin to stabilize. With generally healthy levels of inventory, we continue to be optimistic about our performance in the category. With the recent wins in product distribution and placement, together with the positive pace of sales and consumer acceptance of our innovation, we believe we will continue to outperform the category. While consumers continue to be challenged, we are encouraged by the overall resilience strength of our brand. I'll now move to our home and garden business, which is on slide 15. Net sales increased 3.2% in the quarter, reflecting a delayed start to the season that pushed volume from the third quarter into the fourth quarter. While July experienced favorable weather conditions leading to an improved POS, and strong retailer reorder patterns, unfavorable weather conditions across key regions in the latter half of the quarter negatively impacted POS and shipments. Net sales and controls, which is our largest category in home and garden, were up high teens as Spectrocyte continues to outperform the category. With a strong finish to the quarter in home insect control and herbicides. Household pet, hotshot also gained share with the positive POS while the overall category was flat. We are particularly pleased with the recent innovation launch of our flying insect traps that continues to outperform the rest of the category. Repellent sales were down mid-single digits with softness at key retailers driven by unfavorable weather conditions. Net sales in cleaning were also down for the quarter. As weather patterns evolve, and shift POS into the fall, our late season program continues to gain incremental support from our key account partners with activations for the quarter at four times the number of stores as compared to last year. Our Big Bet innovations are gaining support from our retailers and resonating with consumers. Exceeding our expectations. This year's innovation launch, the Spectracide wasp, hornet, and yellow jacket trap, was a hit with consumers and quickly gained penetration within the category. Earning one of the highest penetrations of any new item in overall pest control. POS performance was above expectations, with additional PAMs to expand distribution and capacity heading into fiscal 2026. The Hotshot flying insect trap launch also performed very well with its strong value proposition. We're excited to see expanded distribution on this new product as well in fiscal 2026. Adjusted EBITDA was $16.9 million compared to $19 million last year. And the adjusted EBITDA margin was 12.1%. 200 basis points lower than the prior year. The decrease in adjusted EBITDA was driven by unfavorable mix, inflation, tariffs, and incremental brand-focused investments partially offset by pricing, productivity improvements, higher sales volume as our innovation continues to resonate with consumers. As we look forward to fiscal 2026, we believe retailer inventory levels are generally healthy, and we expect reorder patterns to closely align with POS. Our sales team will continue to work closely with our retail partners to understand consumer demand expectations and what it means to our production and shipment plan. Expect our category will continue to be well supported by our retail partners, and the strength of our brands will continue to drive share growth. While weather is unpredictable, early indications are that our retail partners expect a normal weather pattern for fiscal 2026. Precipitation and temperatures expected to go back to historical level. Most of the POS for our home and garden business comes in the second half of our fiscal year, with the first half largely focused on preparation and staging for the seasonal business. As a result, timing of inventory builds can vary and impact quarterly results. Our fiscal 2025 first quarter benefited from an earlier than normal seasonal inventory build as well as a pull forward of orders in advance of our S/4 go-live by certain retailers that we would not expect to repeat in fiscal 2026. Overall phasings of net overall phasings net sales in home and garden are therefore expected to be similar to fiscal 2024. And finally, moving to home and personal care, which is slide 16. Reported net sales decreased 11.9%. Excluding favorable foreign exchange, organic net sales decreased 13.4%. Net sales in the personal care category were down low single digits this quarter while sales in home appliances were down double digits. Organic net sales in EMEA were down double digits with softness in both home appliances and personal care. Lower consumer confidence continues to be a headwind in European markets. Impacting both personal care and home appliances categories. We have also seen an influx of Chinese competitors targeting the region in response to the higher tariffs in the US. We continue to be nimble and evaluate new strategies to ensure our brands, remain relevant to our consumers in the current environment. As the consumer moves increasingly to digital markets, our near-term focus is increasing our digital shelf space and ensuring our presence in all relevant channels. In addition, one of our retailers experienced high inventory levels following a major sales event that negatively impacted replenishment orders within the quarter. North American sales decreased around 25% driven by lower sales from appliances. Much like GPC, HPC's fourth quarter results were impacted by inventory availability constraints from the six to eight weeks pause on Chinese sourced products to the US when tariffs were at their highest point. Our inventory levels are now generally healthy, and shortages are not expected to be a significant headwind heading into fiscal 2026. Overall share was also impacted by pricing taken to offset cost of tariffs. May recall last quarter, that we were one of the first to negotiate pricing with our retail partners. And thus, our product was among the first to see tariff-related price increase hit the shelves. We expect that this will normalize in the coming months as pricing goes into effect across the categories. Personal care appliances sales increase in both brick and mortar and e-commerce channels, benefiting from a softer prior year comparison. Organic net sales in LatAm grew high single digits with growth in both categories driven by new product launches in personal care, and distribution gains in the cooking category within home appliances. On the commercial side, you may recall we recently launched the PowerXL Air Max at Walmart, and our ad campaign is seeing strong consumer engagement. We also recently launched our Remington gloss collection exclusively at Target stores target.com. The new line of styling tools is designed to deliver high gloss results and offer a wide variety of styling tools. In LatAm, our Remington brand, saw record quarterly sales in the fourth quarter, after brand refresh initiatives resulting in distribution gains. LATAM continues to be a compelling market for our HPC business. And we are excited about our plans to introduce our Russell Hobb brands to the market in the coming month. We continue to be pleased with our launch on TikTok in the UK. Where our products are resonating with consumers, closing the year with another record month. We plan to build upon the success we're seeing in the UK and take these best practices to other markets in the near future. This quarter's adjusted EBITDA was $15.7 million compared to $19 million in the prior year. The adjusted EBITDA margin was 5.3%. The decline in adjusted EBITDA was driven by lower volumes, unfavorable mix, and tariffs. These significant headwinds were largely offset by pricing lower brand-focused investments in light of tariff supply issues, reduced distribution costs, and expense management as we actively address our fixed cost structure. As we look forward to fiscal 2026, we expect softness in global consumer demand for durables to continue. Compared to the prior year, this is expected to be most impactful to our first quarter results. In North America, tariff-related disruptions are expected to reduce sales volume as we prioritize our overall financial health and right-size the business. HPC will continue to evolve as we reduce our US queue count to simplify our chain and diversify our supply base, while maintaining overall profitability through increased scale on a smaller subset of product offerings. In EMEA, our largest market, we expect category softness and increased competition to continue while we expand our presence in the direct-to-consumer channel helping to partially offset consumer confidence headwinds. Now turning to slide 17, our expectations of fiscal 2026. We expect net sales to be flat to up low single digits compared to the prior year. While we expect growth in both our home personal by in our global pet care and home and garden business, our home and personal care business is expected to decline due to continued category softness and our supply chain simplification initiative the North American market. Adjusted EBITDA is expected to grow low single digits driven by the return to sales growth in our global pet care and home and garden business continued expense management, continuous improvement initiatives, and FX favorability, offsetting lower volumes in home and personal care. Tariffs are expected to be largely offset through the various mitigation actions which we have taken. Including pricing. I do want to point out that in our model, we have fiscal 2026 corporate at approximately $66 million, up from $54 million in fiscal 2025. As you will recall, in fiscal 2025, we had a little over $20 million in TSA cost reimbursements from our sale of HHI that do not repeat in fiscal 2026. We have mitigated approximately half of the cost headwind thus far and intend to address the remaining $10 million during the coming quarters. From a phasing perspective, we expect the first quarter to be the most challenged, primarily due to the shift in consumer sentiment in the middle of the prior year prior fiscal year. We also expect retailer reorder patterns will generally more closely align with POS, which is expected to be most impactful to our home and garden business given the earlier buy-in of inventory in fiscal 2025. And lastly, adjusted free cash flow conversion as a percentage of adjusted EBITDA is expected to be around 50% as we continue to prioritize the strength of our balance sheet. Depreciation and amortization is expected to be between $115 million and $125 million. Including stock-based compensation of approximately $20 to $25 million, cash payments towards restructuring, optimization, strategic transaction costs expected to be between $25 million and $35 million. Capital expenditure expected to be between $50 and $60 million. Cash taxes are expected to be between $40 and $50 million. For adjusted EPS, we use an effective tax rate of 28%, including state taxes. To end my section, I want to echo David and thank all of our global employees for their hard work during these very challenging times. Back to you, David.